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ABSTRACT 
Background: Hiatal hernia with dyspeptic complaints is a severe disease which disturbs the quality of life. Pathological 
findings in endoscopy are an important factor in the treatment of these patients. Objective: To investigate the 
histopathological differences related to hiatal hernia in dyspeptic patients. Material and Methods: A retrospective study was 
conducted of 116 patients with dyspeptic complaints. The patients were divided into two groups according to the presence of 
hiatal hernia. Biochemical tests and endoscopic biopsy results of these groups were compared. Results: The mean age of our 
study population was 52.4 years where, 50% were male and 50% were female. Hiatal hernia was found in 44.8% of the 
patients and 22.4% of the patients had intestinal metaplasia. The rate of intestinal metaplasia was found to be statistically 
lower in the hiatal hernia group (p=0.011). Conclusion: Intestinal metaplasia is less frequently found in patients with hiatal 
hernias in our study; it may be attributed to the fact that these patients had earlier dyspeptic complaints and therefore, earlier 
medical treatment and earlier initiation of a protective gastric diet. 
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iatal hernia (HH) has a high prevalence in 
economically developed Western countries and 
low prevalence in economically underdeveloped 
countries such as Africa. HH is more common in older 
people and is more common in females than in males [1,2]. 
HH is a protrusion of the stomach into the mediastinum 
through a defect in the esophageal hiatus of the diaphragm. 
HH is not a part of any disease but it is a common 
anatomic disorder [3]. Although, the reason of the HH is 
often unknown; extraction of stomach due to esophageal 
contraction and high intra-abdominal pressure or due to 
deficit of frenoesophageal junction can be determined as a 
reason [4]. There are generally two types of hiatal hernia; 
sliding and paraesophageal. HH is commonly 
asymptomatic and is often diagnosed incidentally when 
evaluating other dyspeptic problems [4]. The symptoms 
associated with a hiatal hernia generally are related to  
 
esophageal compression and distortion leading to some 
degree of esophageal obstruction. Dysphagia and 
regurgitation are common symptoms and those ruin the 
quality of life [5]. Symptoms related to regurgitation, such 
as recurring aspiration pneumonia, recurring sinus 
infections, recurring and persistent cough, asthma, and 
changes in voice quality and strength may also occur [5,6]. 
Upper gastrointestinal (GI) endoscopy should be an early 
step within these symptoms. Upper GI contrast 
radiography is also very helpful in establishing the 
diagnosis and extent of a hiatal hernia [7]. 
Gastric intestinal metaplasia is a precancerous lesion 
associated with an increased risk of dysplasia and cancer 
[8]. Intestinal metaplasia (IM) occurs with the replacement 
of surface, foveolar, and/or glandular epithelium in the 
oxyntic or antral mucosa by intestinal epithelium [8]. 
H 
Vural et al                                                                               Histopathological examination of dyspeptic patients  
Vol 3| Issue 3| July – Sept 2018                                                                                 Eastern J Medical Sciences 45                                                                     
Helicobacter pylori infection and related genomics have 
been associated with the development of gastric intestinal 
metaplasia including host genetic factors, environmental 
factors, rheumatologic disorders, diet and intestinal 
microbiology [9]. It is known that intestinal type of gastric 
adenocarcinoma is highly co-related with intestinal 
metaplasia [10]. The aim of this study was to investigate 
the histopathological differences related with hiatal hernia 
in dyspeptic patients.  
MATERIALS & METHODS 
Current retrospective analysis was performed on hospital 
data of adult patients who were treated at a University 
Hospital of Turkey between March 2018 and June 2018.  
Patients with dyspeptic complaints including epigastric 
pain, early satiety, postprandial distress, were eligible for 
enrollment in the study. Patients who had taken H. pylori 
treatment six month before the study were excluded. 
Results of blood samples including hematologic and 
biochemical tests, endoscopic biopsy specimens, and 
extensive radiologic procedures, were obtained from 
hospital data. Patients routinely underwent upper GI 
endoscopy and to identify both microorganism and 
intestinal metaplasia, gastric biopsy materials, from study 
patients, were examined. Endoscopic procedures were 
performed by a gastroenterology doctor at the study 
hospital. Gastric biopsy samples were tested for urease 
activity by using a commercial hp fast test (GI Supply® • 
Camp Hill, PA, USA) which has a urea containing 
medium and a pH reagent. Intestinal metaplasia and 
atrophic gastritis were evaluated by an expertise 
pathologist.  
Obtained results were compared with dyspeptic control 
population wherein, the controls were also required to be 
medical treatment free for at least 6 months from the time 
of study entry. Antrum biopsies of dyspeptic subjects 
without hiatal hernia were examined for both H.pylori and 
premalignant lesions of the gastric mucosa by the same 
method. Prognostic values of H.pylori and other 
clinicopathologic factors were also evaluated. According 
to the endoscopic and radiologic results patients were 
divided into two groups i.e. hiatal hernia group and 
without hiatal hernia group. These two groups were 
compared in terms of blood tests results and biopsy results. 
Statistical analysis was performed and two-sided P 
values of 0.05 or less were considered to indicate statistical 
significance. All statistical analyses were performed with 
the use of SAS software, version 9.3 (SAS Institute). 
RESULTS 
A total number of 116 patients with dyspeptic complaints 
who underwent endoscopy were included in the study. The 
mean age of our study population was 52,4.±12.2 years 
and50% were male and 50% were female. Hiatal hernia 
was found in 52 (44.8%) of the patients and 22.4% of the 
patients had intestinal metaplasia. Rest of the patients (64 
patients; 55.2%) had no hiatal hernia. The patients in our 
study were classified into 2 groups: patients with hiatal 
hernia (n=52) and patients without hiatal hernia (n=64) 
according to endoscopic results. There was no statistically 
significant difference in mean age and biochemical tests 
results except ALP levels between two groups. There was 
also no statistically difference in gender and H. Pylori 
infection between two groups (Table 1). 
Table 1 - Demographic and laboratory characteristics 
of Hiatal Hernia and without Hiatal Hernia Group 
Variable  Hernia 
Group 
(n=52)  
Without 
Hernia 
Group 
(n=64) 
P 
value  
Age (years) 50.2±15.4 54.3±12.3 0.1 
Gender (n%) 
Male  31(59.6%) 27(42.2%) 0.06 
Female  21(40.4%) 37(57.8%)  
Hemoglobin[g/dL] 13.1±2.0 12.2±2.6 0.05 
Hemotocrit [%] 39.8±5.7 37.9±7.7 0.15 
WBCX103 mL  7.6±2.1 7.4±2.7 0.66 
Platelets x103 mL 244.3±70.4 259.4±66.0 0.24 
ALT[U/L] 26.5±21.7 21.8±16.9 0.21 
AST[U/L] 24.1±10.8 21.1±8.7 0.12 
ALP 85.5±30.2 126.9±79.6 0.018 
GGT 25.0±22.5 27.5±28.4 0.69 
Total Bilirubin 0.6±0.4 0.7±1.3 0.68 
Direct Bilirubin 0.2±0.1 0.2±0.2 0.16 
H.Pylori (n,%) 
Positive 26(50%) 35(54.6%) 0.61 
 Negative 26(50%) 29(45.4%)  
Data expressed as mean±SD, categorical variables are 
reported as number (percentage). WBC- white blood cell ; 
ALT-  alanine aminotransferase; AST- aspartate 
aminotransferase; ALP- Alkaline Phosphatase; GGT- 
gamma glutamyl transferase; H.Pylori- Helicobacter Pylori  
According to pathology results intestinal metaplasia 
was detected in 26 patients of the total study population 
(22.4 %). Intestinal metaplasia was found in 11.5% of the 
patients in hiatal hernia group and also was found in 31.3 
% of patients without hiatal hernia group. The rate of 
intestinal metaplasia was found to be statistically lower in 
the hiatal hernia group (P=0.011) (Table 2). 
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Table 2 - The Presence of Intestinal Metaplasia and 
Helicobacter Pylori in Patients with or Without Hiatal 
Hernia 
Tested 
Parameters 
Hiatal Hernia P Value 
Positive 
(n=52) 
Negative 
(n=64) 
Intestinal Metaplasia (n,%) 
Positive  6(11.5%) 20(31.2%) 0.011 
Negative 46(88.5%) 44(68.8%)  
H.Pylori (n, %) 
Positive  26(50%) 35(54.6%) 0.61 
Negative  26(50%) 29(45.4%)  
 
DISCUSSION  
Hiatal hernia occurs when the normal anatomic 
relationship of the diaphragmatic hiatus is impaired by the 
gastroesophageal junction. It is a very common 
pathological condition that can cause gastroesophageal 
reflux. These patients may have stomach ulcers, 
hemorrhages and obstructions. Nevertheless, HH occurs in 
54% to 94% of patients with reflux esophagitis, a rate 
strikingly higher than that in the healthy population [11]. 
Although the etiology of a HH remains unclear, it is 
well known that especially in gastroesophageal reflux 
patients with HH causes Barrett's Esophagus which is a 
precursor to esophageal adenocarcinoma [12]. It was 
determined what kind of lesions lead to gastroesophageal 
reflux and HH in proximal region but also the pathology of 
the hiatal hernia in the distal region, i.e. in the antrum, has 
not been investigated much. 
Intestinal Metaplasis (IM) is a common pathologic 
finding in patients with gastric ulcers and having chronic 
gastritis lead to significant loss of parietal cell mass. This 
oxyntic atrophy may be associated with IM. In previous 
studies, IM was considered as a pre-cancerous lesion; 
however, several studies have investigated the effect of IM 
on gastric ulcer healing and H. pylori eradication [13]. 
Throughout Europe, Asia, and Latin America ranging 
from 10 months to 19 years of follow-up, 10 observational 
studies, a systematic review, showed the risk of gastric 
cancer to be 4- to 11-fold higher with incomplete 
metaplasia compared to without incomplete metaplasia 
[15]. Atrophic gastritis, intestinal metaplasia, mild-
moderate dysplasia, and severe dysplasia were associated 
with annual incidences of gastric cancer of 0.1%, 0.25%, 
0.6%, and 6.0%, respectively [16]. The incidence of gastric 
cancer associated with IM ranges from 0% to 10% in 
systematic reviews, with the variable range attributable to 
various sample sizes and follow-up periods [17,18]. 
We have investigated the relationship of HH with IM 
that is important in patients with the development of 
gastric cancer; we found that IM was less statistically 
significant in patients with hiatal hernia.  
There were several limitations of the study.  First,  
small sample size may have been caused a bias against 
control group. Second, due to retrospective nature of the 
study, the results may not have generalised the entire study 
population.  On the other hand, this small study was the 
first in English literature to show a negative association 
between hiatal hernia and intestinal metaplasia.   
CONCLUSION 
Although the mechanisms of IM formation are not fully 
understood yet, IM was less frequently found in patients 
with hiatal hernias in our study; it may be attributed to the 
fact that these patients had earlier dyspeptic complaints 
and therefore earlier medical treatment and earlier 
initiation of a protective gastric diet. 
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